{"id":"https://openalex.org/W2138749477","doi":"https://doi.org/10.1158/1535-7163.mct-09-0201","title":"Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90","display_name":"Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90","alternate_titles":[],"publication_year":2009,"publication_date":"2009-08-01","ids":{"openalex":"https://openalex.org/W2138749477","doi":"https://doi.org/10.1158/1535-7163.mct-09-0201","mag":"2138749477","pmid":"https://pubmed.ncbi.nlm.nih.gov/19671736","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2728724"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-09-0201","doi":"https://doi.org/10.1158/1535-7163.mct-09-0201","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-09-0201","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2138749477"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2728724/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007865366","display_name":"Fiona A. Dungey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I100063501","display_name":"Brighton and Sussex Medical School","ror":"https://ror.org/01qz7fr76","country_code":"GB","type":"education","lineage":["https://openalex.org/I100063501","https://openalex.org/I162608824","https://openalex.org/I71637028"]},{"id":"https://openalex.org/I162608824","display_name":"University of Sussex","ror":"https://ror.org/00ayhx656","country_code":"GB","type":"education","lineage":["https://openalex.org/I162608824"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fiona A. Dungey","raw_affiliation_strings":["1Genome Damage and Stability Centre and 2Brighton and Sussex Medical School, University of Sussex, Falmer, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genome Damage and Stability Centre and 2Brighton and Sussex Medical School, University of Sussex, Falmer, United Kingdom","institution_ids":["https://openalex.org/I100063501","https://openalex.org/I162608824"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058322347","display_name":"Keith W. Caldecott","orcid":"https://orcid.org/0000-0003-4255-9016","observed_orcids":["https://orcid.org/0000-0003-4255-9016"]},"institutions":[{"id":"https://openalex.org/I100063501","display_name":"Brighton and Sussex Medical School","ror":"https://ror.org/01qz7fr76","country_code":"GB","type":"education","lineage":["https://openalex.org/I100063501","https://openalex.org/I162608824","https://openalex.org/I71637028"]},{"id":"https://openalex.org/I162608824","display_name":"University of Sussex","ror":"https://ror.org/00ayhx656","country_code":"GB","type":"education","lineage":["https://openalex.org/I162608824"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keith W. Caldecott","raw_affiliation_strings":["1Genome Damage and Stability Centre and 2Brighton and Sussex Medical School, University of Sussex, Falmer, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genome Damage and Stability Centre and 2Brighton and Sussex Medical School, University of Sussex, Falmer, United Kingdom","institution_ids":["https://openalex.org/I100063501","https://openalex.org/I162608824"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070984695","display_name":"Anthony J. Chalmers","orcid":"https://orcid.org/0000-0002-1746-7278","observed_orcids":["https://orcid.org/0000-0002-1746-7278"]},"institutions":[{"id":"https://openalex.org/I100063501","display_name":"Brighton and Sussex Medical School","ror":"https://ror.org/01qz7fr76","country_code":"GB","type":"education","lineage":["https://openalex.org/I100063501","https://openalex.org/I162608824","https://openalex.org/I71637028"]},{"id":"https://openalex.org/I162608824","display_name":"University of Sussex","ror":"https://ror.org/00ayhx656","country_code":"GB","type":"education","lineage":["https://openalex.org/I162608824"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anthony J. Chalmers","raw_affiliation_strings":["1Genome Damage and Stability Centre and 2Brighton and Sussex Medical School, University of Sussex, Falmer, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genome Damage and Stability Centre and 2Brighton and Sussex Medical School, University of Sussex, Falmer, United Kingdom","institution_ids":["https://openalex.org/I100063501","https://openalex.org/I162608824"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5070984695"],"corresponding_institution_ids":["https://openalex.org/I100063501","https://openalex.org/I162608824"],"apc_list":null,"apc_paid":null,"fwci":5.3264,"has_fulltext":false,"cited_by_count":122,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96284503,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"8","issue":"8","first_page":"2243","last_page":"2254"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11176","display_name":"Radiation Therapy and Dosimetry","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/3108","display_name":"Radiation"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9390000104904175},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.9309999942779541},{"id":"https://openalex.org/keywords/poly-adp-ribose-polymerase-inhibition","display_name":"poly(ADP-ribose) polymerase inhibition","score":0.949999988079071},{"id":"https://openalex.org/keywords/17-allylamino-17-demethoxygeldanamycin","display_name":"17-allylamino-17-demethoxygeldanamycin","score":0.9660000205039978},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.9089999794960022},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.7839999794960022},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":1.0},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.5320000052452087},{"id":"https://openalex.org/keywords/gamma-h2ax","display_name":"\u03b3H2AX","score":0.7459999918937683},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5019999742507935},{"id":"https://openalex.org/keywords/tumor-specificity","display_name":"tumor specificity","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.6495516896247864},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.6182106733322144},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.6023110747337341},{"id":"https://openalex.org/C205260736","wikidata":"https://www.wikidata.org/wiki/Q418939","display_name":"Heat shock protein","level":3,"score":0.5940566658973694},{"id":"https://openalex.org/C2781300812","wikidata":"https://www.wikidata.org/wiki/Q178061","display_name":"Shock (circulatory)","level":2,"score":0.503407895565033},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46045807003974915},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40692412853240967},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.38720938563346863},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3325701057910919},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3226301968097687},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2586323618888855},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2335565984249115},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.20620855689048767},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1347542405128479},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07511353492736816}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011065","descriptor_name":"Poly(ADP-ribose) Polymerases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011836","descriptor_name":"Radiation Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011838","descriptor_name":"Radiation-Sensitizing Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011995","descriptor_name":"Recombination, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016227","descriptor_name":"Benzoquinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018841","descriptor_name":"HSP90 Heat-Shock Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018841","descriptor_name":"HSP90 Heat-Shock Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047029","descriptor_name":"Lactams, Macrocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1158/1535-7163.mct-09-0201","doi":"https://doi.org/10.1158/1535-7163.mct-09-0201","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-09-0201","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:19671736","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19671736","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2728724","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2728724/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"},{"id":"pmh:oai:eprints.gla.ac.uk:42847","doi":null,"is_oa":false,"landing_page_url":"http://eprints.gla.ac.uk/42847/","pdf_url":null,"source":{"id":"https://openalex.org/S7407122635","display_name":"Enlighten: Publications (University of Glasgow)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I7882870","host_organization_name":"University of Glasgow","host_organization_lineage":["https://openalex.org/I7882870"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Articles"},{"id":"pmh:oai:figshare.com:article/23313848","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Enhanced_radiosensitization_of_human_glioma_cells_by_combining_inhibition_of_poly_ADP-ribose_polymerase_with_inhibition_of_heat_shock_protein_90/23313848","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:figshare.com:article/23336966","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Enhanced_radiosensitization_of_human_glioma_cells_by_combining_inhibition_of_poly_ADP-ribose_polymerase_with_inhibition_of_heat_shock_protein_90/23336966","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2728724","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2728724/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2942012775","display_name":null,"funder_award_id":"C6563/A10192","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G3809730391","display_name":null,"funder_award_id":"BB/FOI3930/1","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320334629","display_name":"Biotechnology and Biological Sciences Research Council","ror":"https://ror.org/00cwqg982"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1815105900","https://openalex.org/W1970392870","https://openalex.org/W1973268287","https://openalex.org/W1978356732","https://openalex.org/W1998959684","https://openalex.org/W2000929246","https://openalex.org/W2008430430","https://openalex.org/W2009007206","https://openalex.org/W2009246149","https://openalex.org/W2010383007","https://openalex.org/W2012172048","https://openalex.org/W2019775979","https://openalex.org/W2019963243","https://openalex.org/W2020784028","https://openalex.org/W2020891498","https://openalex.org/W2030733656","https://openalex.org/W2038229034","https://openalex.org/W2051148606","https://openalex.org/W2055097137","https://openalex.org/W2057574712","https://openalex.org/W2061211083","https://openalex.org/W2064720809","https://openalex.org/W2070656260","https://openalex.org/W2096287682","https://openalex.org/W2099627146","https://openalex.org/W2103770333","https://openalex.org/W2105100844","https://openalex.org/W2136367213","https://openalex.org/W2139554694","https://openalex.org/W2151908249","https://openalex.org/W2158818260","https://openalex.org/W2167356883","https://openalex.org/W2529952554","https://openalex.org/W2624719401"],"related_works":["https://openalex.org/W2489605347","https://openalex.org/W2979741302","https://openalex.org/W2070656260","https://openalex.org/W2070093424","https://openalex.org/W4390779670","https://openalex.org/W2742701905","https://openalex.org/W1977074480","https://openalex.org/W2055183302","https://openalex.org/W2040461322","https://openalex.org/W7208823369"],"abstract_inverted_index":{"Glioblastoma":[0],"multiforme":[1],"(GBM)":[2],"are":[3,11,67,92,216,224],"the":[4,27,81,96,117,124,147,237,248],"most":[5],"common":[6],"primary":[7],"brain":[8,21],"tumor":[9,193],"and":[10,61,116,123,131,142,152],"resistant":[12],"to":[13,25,107,218],"standard":[14],"therapies.":[15],"The":[16,111],"nondividing":[17],"nature":[18],"of":[19,35,47,53,77,85,90,114,137,187,221,239,250],"normal":[20],"provides":[22],"an":[23],"opportunity":[24],"enhance":[26],"therapeutic":[28,245],"ratio":[29],"by":[30,69,140,146,171,211],"combining":[31],"radiation":[32,185],"with":[33,167],"inhibitors":[34,89],"replication-specific":[36,82],"DNA":[37,64],"repair":[38],"pathways.":[39],"Based":[40],"on":[41,159],"our":[42],"previous":[43],"findings":[44],"that":[45,66,75,204,223,235],"inhibition":[46,76],"poly(ADP-ribose)":[48],"polymerase":[49],"(PARP)":[50],"increases":[51,172],"radiosensitivity":[52,199],"human":[54],"glioma":[55,161],"cells":[56],"in":[57,173,176,200,226,247],"a":[58,231],"replication-dependent":[59,156,233],"manner":[60],"generates":[62],"excess":[63],"breaks":[65],"repaired":[68],"homologous":[70],"recombination":[71],"(HR),":[72],"we":[73],"hypothesized":[74],"HR":[78,91,109,144,212],"would":[79],"amplify":[80],"radiosensitizing":[83,112,157],"effects":[84,113,158,206,238],"PARP":[86,118,240],"inhibition.":[87,213,241],"Specific":[88],"not":[93,183],"available,":[94],"but":[95],"heat":[97],"shock":[98],"protein":[99,133],"90":[100],"inhibitor":[101,119],"17-allylamino-17-demethoxygeldanamycin":[102],"(17-AAG)":[103],"has":[104,244],"been":[105],"reported":[106],"inhibit":[108],"function.":[110],"17-AAG":[115,128,151,181,196,228],"olaparib":[120,153],"were":[121,207],"assessed,":[122],"underlying":[125],"mechanisms":[126,215],"explored.":[127],"down-regulated":[129],"Rad51":[130,138],"BRCA2":[132],"levels,":[134],"abrogated":[135],"induction":[136],"foci":[139,175],"radiation,":[141],"inhibited":[143],"measured":[145],"I-Sce1":[148],"assay.":[149],"Individually,":[150],"had":[154],"modest,":[155],"T98G":[160],"cells.":[162,178],"Additive":[163],"radiosensitization":[164],"was":[165],"observed":[166],"combination":[168,243],"treatment,":[169],"mirrored":[170],"gammaH2AX":[174],"G(2)-phase":[177],"Unlike":[179],"olaparib,":[180],"did":[182],"increase":[184],"sensitivity":[186],"Chinese":[188],"hamster":[189],"ovary":[190],"cells,":[191,202],"indicating":[192,203],"specificity.":[194],"However,":[195],"also":[197],"enhanced":[198],"HR-deficient":[201],"its":[205],"only":[208],"partially":[209],"mediated":[210],"Additional":[214],"likely":[217],"include":[219],"destabilization":[220],"oncoproteins":[222],"up-regulated":[225],"GBM.":[227,251],"is":[229],"therefore":[230],"tumor-specific,":[232],"radiosensitizer":[234],"enhances":[236],"This":[242],"potential":[246],"management":[249]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2138749477","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":7},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
